Inari Medical Inc

Inari Medical Inc(NARI)股票分析

$79.970

+0.040 (+0.05%)收盘时

Loading chart…
最高
79.990
开盘
79.970
成交量加权均价
79.97
成交量
2.36M
市值
2.73B
最低
79.960
成交额
188.66M
企业价值/息税折旧摊销前利润(TTM)
243.88

Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.

估值指标

Inari Medical Inc(NARI)当前预期市盈率为 305.46,5 年平均预期市盈率为 6.05。

预期市盈率

合理
5 年均值 P/E
6.05
当前P/E
305.46
高估
460.93
低估
-448.82

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
356.73
当前EV/EBITDA
243.88
高估
1726.33
低估
-1012.88

预期市销率

合理
5 年均值 P/S
7.35
当前P/S
6.60
高估
10.08
低估
4.63

NARI 常见问题 —— 由 Alphio AI 解答

Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易